ClinicalTrials.govpublic full text
Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients
end stage renal disease, hemodialysis vascular access failure
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 300361
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.